Sale!

MASTL Gene Thrombocytopenia Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MASTL Gene Thrombocytopenia Type 2 Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the MASTL gene, which are linked to Thrombocytopenia Type 2. Thrombocytopenia Type 2 is a rare genetic disorder characterized by a lower than normal platelet count, leading to increased bleeding and bruising risks. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

The test, which costs 4400 AED, involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic variations in the MASTL gene that may be responsible for the condition. Identifying these mutations can be crucial for the accurate diagnosis, management, and understanding of the disease’s progression in affected individuals. It also provides valuable information for family planning and genetic counseling for families with a history of Thrombocytopenia Type 2. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic testing, ensures high accuracy and reliability of the test results, making it a trusted choice for patients and healthcare providers seeking genetic analysis for Thrombocytopenia Type 2.

Description

MASTL Gene Thrombocytopenia type 2 Genetic Test

Cost: AED 4400.0

Test Components: MASTL Gene Thrombocytopenia type 2 Genetic Test

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MASTL Gene Thrombocytopenia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MASTL Gene Thrombocytopenia type 2 NGS Genetic DNA Test gene MASTL.

Test Details: The MASTL gene is responsible for encoding the microtubule-associated serine/threonine-protein kinase-like protein. Thrombocytopenia type 2 is a rare inherited disorder characterized by a low platelet count in the blood, leading to an increased risk of bleeding. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of thrombocytopenia type 2, NGS genetic testing can be used to identify mutations or variations in the MASTL gene that may be causing the disorder. By sequencing the entire coding region of the MASTL gene, NGS can provide a comprehensive analysis of genetic variations and identify any pathogenic mutations. This information can help in the diagnosis, prognosis, and management of thrombocytopenia type 2. It is important to note that NGS genetic testing for thrombocytopenia type 2 should be performed by a qualified geneticist or genetic counselor, as the interpretation of the results and their implications can be complex. Genetic counseling is recommended to discuss the results, inheritance patterns, and any potential implications for family members.

Test Name	MASTL Gene Thrombocytopenia type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MASTL Gene Thrombocytopenia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MASTL Gene Thrombocytopenia type 2 NGS Genetic DNA Test gene MASTL
Test Details	The MASTL gene is responsible for encoding the microtubule-associated serine/threonine-protein kinase-like protein. Thrombocytopenia type 2 is a rare inherited disorder characterized by a low platelet count in the blood, leading to an increased risk of bleeding. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of thrombocytopenia type 2, NGS genetic testing can be used to identify mutations or variations in the MASTL gene that may be causing the disorder. By sequencing the entire coding region of the MASTL gene, NGS can provide a comprehensive analysis of genetic variations and identify any pathogenic mutations. This information can help in the diagnosis, prognosis, and management of thrombocytopenia type 2. It is important to note that NGS genetic testing for thrombocytopenia type 2 should be performed by a qualified geneticist or genetic counselor, as the interpretation of the results and their implications can be complex. Genetic counseling is recommended to discuss the results, inheritance patterns, and any potential implications for family members.